Finance entity

OmniMetrix

Company

Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Acorn Energy, Inc., the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.3 for that window.

Last mentioned: Mar 6, 2026

Entity pulse

Recent coverage · OmniMetrix

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about OmniMetrix

Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention Acorn Energy, Inc., the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.3 for that window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. We currently track 1 Finance story that mention OmniMetrix, all published on March 6, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering OmniMetrix. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Earnings Calls

    Management teams for both companies host conference calls to provide strategic updates and 2026 outlook.

  2. Transcript Release

    Full transcripts of the Q4 2025 earnings calls are made available to the public and analysts.

  3. SEC Filings

    Both ACFN and CRMD file 8-K reports detailing Q4 and full-year 2025 financial results.

Stories mentioning OmniMetrix 1

Earnings Neutral

Micro-Cap Execution: Acorn Energy and CorMedix Deliver Q4 2025 Results

Acorn Energy and CorMedix both reported Q4 2025 financial results on March 5, 2026, marking a critical transition from development to commercial scaling. While Acorn focuses on high-margin IoT recurring revenue, CorMedix is navigating the complex rollout of its lead product, DefenCath, in the dialysis market.

2 sources

OmniMetrix is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.